TD Asset Management
EVMN

TD Asset Management’s Evommune Inc EVMN Stock Holding History

TD Asset Management’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$806K Buy
60,662
+20,452
+51% +$475K ﹤0.01% 1125
2026
Q1 		$924K Sell
40,210
-4,424
-10% -$100K ﹤0.01% 1102
2025
Q4 		$764K Buy
+44,634
New +$838K ﹤0.01% 1133

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

TD Asset Management's EVMN Position: Q2 2026 in Review

TD Asset Management increased its Evommune Inc (EVMN) stake by 51% in Q2 2026, buying an estimated $475K and bringing the position to 60,662 shares worth $806K. The position accounts for ﹤0.01% of the portfolio, ranked #1125.

TD Asset Management first reported a position in EVMN in Q4 2025 and has held it in 3 quarters since. The position peaked at $924K in Q1 2026. 105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • TD Asset Management held 60,662 shares of Evommune Inc worth $806K as of Q2 2026.
  • TD Asset Management bought 20,452 Evommune Inc shares in Q2 2026, an estimated $475K.
  • Evommune Inc made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1125 holding.
  • TD Asset Management first reported a position in Evommune Inc in Q4 2025 and has held it in 3 quarters since.
  • TD Asset Management's Evommune Inc position peaked at $924K in Q1 2026.
  • 105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.